[Federal Register Volume 73, Number 101 (Friday, May 23, 2008)]
[Notices]
[Page 30105]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-11589]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control; Special 
Emphasis Panel (SEP): Associations of Vaccine Adverse Events and Human 
Genetic Variations, Request for Proposal Number (RFP) 2008-R-VAC01

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12 p.m.-2 p.m., June 12, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of proposals received in response to 
``Associations of Vaccine Adverse Events and Human Genetic 
Variations, Request for Proposal (RFP) Number 2008-R-VAC01.''
    Contact Person for More Information: Christine J. Morrison, PhD, 
Scientific Review Administrator, CDC, 1600 Clifton Road, NE., 
Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-11589 Filed 5-22-08; 8:45 am]
BILLING CODE 4163-18-P